STOCK TITAN

BioLife CMO has 470 shares withheld for taxes

BLFS’s chief marketing officer had shares withheld to cover taxes on vested restricted stock units, leaving a direct holding of 161,823 shares.

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

BIOLIFE SOLUTIONS INC (BLFS) reported that Chief Marketing Officer Todd Berard had 470 shares of common stock withheld on September 18, 2026 to satisfy tax withholding obligations arising from the release of restricted stock units. After this tax-withholding disposition, he holds 161,823 shares of common stock directly. No transactions were reported under a Rule 10b5-1 trading plan.

Positive

  • None.

Negative

  • None.
Insider Berard Todd
Role Chief Marketing Officer
Type Security Shares Price Value
Tax Withholding Common Stock F1 470 $36.69 $17K
Holdings After Transaction: Common Stock — 161,823 shares (Direct)
Footnotes (1)
  1. F1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Shares withheld for tax withholding obligations 470 shares Common stock withheld on September 18, 2026 to satisfy tax withholding from RSU release
Price per share for tax-withholding disposition $36.69 per share Value used for the 470-share tax-withholding transaction on September 18, 2026
Shares owned after transaction 161,823 shares Total direct holdings of common stock by Todd Berard following the withholding
restricted stock units financial
"arose upon the release of restricted stock units"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding obligations financial
"to satisfy tax withholding obligations of the reporting person"
withheld by the Issuer financial
"Represents the number of shares withheld by the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BLFS Chief Marketing Officer Todd Berard report?

Todd Berard reported that 470 shares of BIOLIFE SOLUTIONS INC common stock were withheld on September 18, 2026 to satisfy tax withholding obligations triggered by the release of restricted stock units. This reflects a tax-related disposition rather than an open-market trade.

How many BLFS shares does Todd Berard hold after this Form 4 transaction?

After the reported tax-withholding transaction, Todd Berard holds 161,823 shares of BIOLIFE SOLUTIONS INC common stock directly. This figure is disclosed as his total direct ownership following the September 18, 2026 withholding event.

Was the BLFS insider transaction by Todd Berard an open-market sale?

No. The filing states the transaction was a payment of tax liability by delivering or withholding securities. The 470 shares were withheld by the issuer to cover taxes upon release of restricted stock units, not sold in the open market.

What price per share is associated with Todd Berard’s BLFS tax-withholding transaction?

The tax-withholding disposition of 470 shares is reported at a price of $36.69 per share. This per-share value is used for the calculation of the tax withholding amount tied to the restricted stock unit release.

Was Todd Berard’s BLFS Form 4 transaction under a Rule 10b5-1 trading plan?

No. The filing indicates that the Rule 10b5-1 checkbox is not selected, so no Rule 10b5-1 trading plan is reported in connection with this tax-withholding transaction by Todd Berard.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Berard Todd

(Last)(First)(Middle)
3303 MONTE VILLA PARKWAY
SUITE 310

(Street)
BOTHELL WASHINGTON 98021

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
BIOLIFE SOLUTIONS INC [ BLFS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Marketing Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/18/2026F470(1)D$36.69161,823D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the number of shares withheld by the Issuer to satisfy tax withholding obligations of the reporting person that arose upon the release of restricted stock units.
Remarks:
/s/ Todd Berard09/22/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading